|
MITOCHONDRIAL DISEASE
A New York IVF clinic has been told by the FDA to stop marketing Mitochondrial Replacement Therapy.
Not everyone is enthusiastic
It expects 20 patients in the first half of the year
Not as straightforward as scientists have painted it
Is a knighthood part of a publicity campaign for three-parent embryos?
The world’s most prestigious science journal, Nature, has thrown its weight behind the legalisation of “three-parent embryos”.
Chief Medical Officer announces the launch of a consultation.
Opponents of the UK’s plans to legalise “three-parent embryos” have not given up.
The UK is moving closer to three-parent children after the fertility regulator informed the government that the public would back a controversial embryo treatment.
The UK’s fertility watchdog has launched a public consultation on the ethics of IVF-based techniques designed to avoid serious mitochondrial diseases.
The controversial practice known as “three-parent IVF” has drawn one step closer in the UK with the government’s announcement of public consultation into its acceptability. The Wellcome Trust has also announced that it would allocate extra funds to expand research into the technique, which uses genetic material from 3 parents – 2 women and a man – to build a baby. The procedure, which currently banned, is a response to mitochondrial disease – defects in the small frameworks called mitochondria which surround the cell nucleus.
|
|
|